Latest News, Updates & Breaking Headlines
US trade representatives emphasised to their Indian colleagues that addressing the Russian oil issue was essential. (AI image) India-US trade deal is contingent on India curbing its Russian crude oil imports, US trade negotiators have reportedly told Indian officials. Trade officials from the United States have informed India’s negotiators that a curb in Russian oil…
India exports a significant amount of pharmaceutical drugs to the US. (AI image) US President Donald Trump’s latest announcement of 100% tariffs imported branded or patented pharmaceutical products has sent shockwaves through pharma companies around the world.Trump announced on Truth Social that effective October 1, 2025, a 100% tariff will be applicable on imported branded…
Randhir Jaiswal (File photo) NEW DELHI: India on Friday issued its first official response to reports that US President Donald Trump announcing imposition of tariffs of up to 100 per cent on imports of branded and patented pharmaceutical drugs from October 1.During the weekly briefing, MEA’s official spokesperson Randhir Jaiswal said, “We saw a notice…
Since the Russia-Ukraine conflict began in 2022, India has significantly increased its crude oil imports from Russia. (AI image) India, faced with 25% additional penal tariffs for its crude trade with Russia, has reportedly asked the US to allow oil imports from Iran and Venezuela.Following international sanctions due to the Ukraine conflict, Russia began offering…
For Indian pharmaceutical exports, the US represents the primary market, comprising approximately 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…
Asian drug stocks fell on Friday as investors reacted to US President Donald Trump’s threat to impose 100% tariffs on imported branded pharmaceuticals starting October 1.Companies without existing US manufacturing plants could face the full impact, triggering declines across major drugmakers in South Korea, Japan, and Hong Kong.In South Korea, Samsung Biologics fell 1.6%, while…
Asian markets opened cautiously on Friday after US President Donald Trump announced a fresh set of tariffs, while investors lowered expectations for significant Federal Reserve interest rate cuts following stronger-than-anticipated economic data.Trump revealed plans to levy a 100% tariff on imported branded pharmaceuticals, 25% on heavy-duty trucks, and 50% on kitchen cabinets. He also said…
Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…
US President Donald Trump on Friday announced a 100% tariff on pharma products, along with 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on October 1.The announcements came in a series of posts on his social media platform indicating that he remains committed to tariffs beyond…
Congress MP Shashi Tharoor during the interview NEW DELHI: Congress MP and former minister of state for external affairs Shashi Tharoor on Tuesday called the US administration’s recent trade and visa decisions a “sharp setback” for India, given PM Modi’s visit to the US after Trump’s inauguration. Speaking to ANI, Tharoor recalled that Prime Minister…
